Ponoi II Management, LLC
Follow13F filer, CIK 1746488, San Francisco, CA
Ponoi II Management, LLC reported $38,258,000 across 4 holdings for the quarter ended 2022-09-30, in a 13F-HR filed 2022-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-22-012307
- Period
- 2022-09-30
- Reported value
- $38.3M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q3 2022
Share positions as resolved from 13F-HR 0000950123-22-012307, largest first. % of portfolio is the value over $38,258,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC | 1,298,908 | $17M | 44.41% | 0 | |||
| RVMDREVOLUTION MEDICINES INC | 685,011 | $13.5M | 35.31% | 0 | Timeline | ||
| NRIXNURIX THERAPEUTICS INC | 327,123 | $4.26M | 11.14% | 0 | Timeline | ||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 145,401 | $3.5M | 9.14% | 0 |
How Q3 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-22-012307 | base | 2022-11-14 | acceptance time not in the bulk data set |